Schuyler T Eldridge

Schuyler T. Eldridge serves as a Contracting Officer responsible for managing complex procurements within the biomedical and medical device sectors. In this role, he ensures compliance with federal acquisition regulations while advancing mission-critical health technology acquisitions. His portfolio centers on the procurement of biological products and surgical/medical instruments, requiring deep technical understanding of manufacturing standards, quality control protocols, and regulatory alignment with FDA requirements. Eldridge oversees full lifecycle contracting activities—from market research and solicitation development to award administration and contract closeout—ensuring timely delivery of essential medical supplies and biomanufacturing capabilities. While no specific contractor relationships are currently identifiable in the data, Eldridge’s procurement patterns indicate engagement with a range of manufacturers possessing cGMP certification, ISO 13485 compliance, and experience in sterile product production. His contracting approach emphasizes performance-based outcomes and risk mitigation, often requiring vendors to demonstrate validated manufacturing processes and robust supply chain controls. He works closely with technical evaluators and quality assurance specialists to ensure awarded contracts meet stringent biomedical standards. Eldridge’s contracting portfolio is entirely non-set-aside, with 100% of awards issued under full and open competition. This reflects a strategic focus on maximizing technical capability and manufacturing scale rather than socioeconomic set-asides, though he remains committed to fair and transparent competition that allows all qualified firms—regardless of size or certification—to compete on merit. His primary procurement focus lies in NAICS 325414 (Biological Product Manufacturing), where he acquires therapeutics, vaccines, and biologics requiring controlled environments and regulatory oversight, and NAICS 339112 (Surgical and Medical Instrument Manufacturing), where he procures precision devices for clinical use. His expertise spans sterile fill-finish operations, lyophilization, and Class II/III medical device procurement, positioning him as a specialist in high-stakes biomedical acquisitions.